.webp)
Africa
The work we do
Africa has set an ambitious goal to produce at least 60% of its vaccines locally by 2040. Led by Africa CDC, the continent is working towards this ambition through the Platform for Harmonized African Health Manufacturing (PHAHM).
RVMC works with Africa CDC and partners to help turn this ambition into a sustainable vaccine supply. We support manufacturers in identifying and overcoming barriers to production, financing, and market access, while collaborating with AUDA-NEPAD and the African Medicines Agency on regulatory readiness. We also connect African partners with other regions to share practical experience, including lessons from PAHO's Revolving Fund on coordinating vaccine procurement and demand to support regional production.
African Vaccine Manufacturing Supply Landscape
The 2026 African Vaccine Manufacturing Supply Landscape, developed by the Clinton Health Access Initiative (CHAI), highlights progress in Africa's manufacturing ambitions. Six manufacturers have facilities with technology transfers underway, while 11 African-made vaccines are expected to reach the continental market within the next five years.
However, manufacturing capacity alone does not guarantee vaccine supply. Regulatory delays, uncertain demand, financing gaps and workforce shortages continue to slow progress. The priority now is to align investment, procurement and regulatory support around manufacturers and products approaching the market, helping translate growing capacity into sustainable regional supply.
RVM Insights
The RVM Insights Hub brings together evidence to help you understand what's changing, where challenges remain, and what comes next.
Explore our data and insights on vaccine manufacturing in Africa, covering manufacturing capabilities and regional supply, as well as the gaps and opportunities for progress.
0
The number of vaccine manufacturers in Africa producing five or more vaccines, with integrated manufacturing, annual capacity exceeding 70 million doses and active exports.
1%
The share of regional vaccine demand in Africa, met by manufacturers within the region
1 of 16
The number of regional priority diseases for which at least one commercial vaccine is produced by a regional manufacturer
Related Resources
Other regions of focus
ASEAN
ASEAN has a strong vaccine manufacturing base, but fragmented markets limit its potential. Explore how RVMC is supporting regional cooperation to strengthen vaccine security and self-reliance.
LAC
With established manufacturing capabilities and regional procurement mechanisms, LAC has strong foundations to build on. Learn how RVMC is supporting sustainable regional supply and sharing lessons across regions.
